NVS

Novartis AG (NVS)

Last Price$97.5(0.3%)
Market Cap$196.2B
LTM Operating Income
$13.8B
YoY Growth
+45.1%
3Y CAGR
+5.4%
5Y CAGR
+10.0%
Stock quality & Intrinsic value

Novartis AG Operating Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income
$6,539.0M
$6,905.0M
$7,949.0M
$6,781.0M
$8,964.0M
$9,982.0M
$11.5B
$11.0B
$11.5B
$10.9B
$11.1B
$8,977.0M
$8,268.0M
$8,629.0M
$8,169.0M
$9,086.0M
$10.2B
$26.9B
$9,197.0M
$9,769.0M
NVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVS and see if it's the right time to invest.
Dive in

Novartis AG (NVS) Operating Income comparison analysis

Crunching data... Almost there!

NVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Novartis AG's Operating Income?

As of today, Novartis AG's last 12-month Operating Income is $13.8B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Novartis AG's Operating Income growth rate?

Over the last year, Novartis AG's Operating Income growth was 45.1%. The average annual Operating Income growth rates for Novartis AG have been 11.9% over the past three years, 10.0% over the past five years.

3) Is Novartis AG's Operating Income growth rate Good?

Over the last year, Novartis AG's Operating Income growth was 45.1%, which is higher than industry growth of 0.0%. It indicates that Novartis AG's Operating Income growth is Good.

4) How does Novartis AG's Operating Income growth rate compare to its peers?

Over the last year, Novartis AG's Operating Income growth was 45.1%, which is higher than peer median growth of 16.8%. The list of peers includes JNJ, MRK, LLY, SNY, ABBV, BMY, PFE, AZN, GILD, AMGN etc.